Viatris’ commercial business in India was launched in 2012 under Mylan Pharmaceuticals Private Limited to provide patients access to high-quality, affordable medicines. We offer a wide-ranging portfolio of products for therapeutic areas such as infectious diseases, gastro and transplant care, hospital care, oncology, non-communicable diseases, and dermatology.
"Through our commercial acumen, we hold leadership positions in the categories where we have a presence and help our patients reach their treatment goals. We are working on path-breaking initiatives that would enable us to differentiate ourselves in the market, become a partner of choice for our customers and accelerate growth."
Praveen Singh Chauhan, Country Manager, India Commercial
“We are committed to meaningfully reducing the burden of non-communicable and infectious diseases. Our deep experience affords a tried-and-true method of achieving high impact across the patient experience, from awareness to adherence.”
S Venkatachalam, Associate Vice President, India Commercial
"Our vision is to establish Viatris as a trusted partner to achieve the mission of TB-free India, with a strategy focused on the patient journey to enhance diagnostic access and build clinical capabilities. We are also deeply committed to contributing towards a comprehensive healthcare ecosystem with increased access to critical, high-quality medicines at an affordable price."